20.500.12556/DiRROS-13875 Selective response to omalizumab in a patient with concomitant ncMCAS and POTS : what does it teach us about the underlying disease? mastocytosis postural orthostatic tachycardia syndrome omalizumab nonclonal mast cell activation syndrome mastocitoza posturalna ortostatska tahikardija omalizumab neklonski sindrom aktivacije mastocitov true false true ESMON Publicidad Angleški jezik Ni določen © 2018 Esmon Publicidad Neznano 2021-04-08 14:56:14 2021-04-08 14:56:14 2022-08-19 03:37:20 0000-00-00 00:00:00 2018 0 Španija 0 Nasl. z nasl. zaslona; Opis vira z dne 7. 4. 2021; str. 261-263 iss. 4 Vol. 28 2018 0000-00-00 Zaloznikova Objavljeno NiDoloceno 0000-00-00 0000-00-00 0000-00-00 616-097 1698-0808 10.18176/jiaci.0251 58573827 http://www.jiaci.org/revistas/vol28issue4_9.pdf 1 https://dirros.openscience.si/Dokument.php?lang=slv&id=16987 Univerzitetna klinika za pljučne bolezni in alergijo Golnik 0 0 0